N6‐methyladenine Profiling of Low‐input Multiplex Clinical Samples on Transcriptome Reveals RNA Modifications Implicated in Type 2 Diabetes and Acute Myocardial Infarction

Shanshan Qin,Kun Yang,Shaoqing Han,Yushu Yuan,Jing Mo,Mengyao Xiao,Yin Yang,Yafen Wang,Xin Fang,Fang Wang,Wei Zhang,Song-Mei Liu,Xiaocheng Weng,Xiang Zhou
DOI: https://doi.org/10.1002/ctm2.1165
IF: 8.554
2023-01-01
Clinical and Translational Medicine
Abstract:Dear Editor, RNA N6-methyladenines (m6A) not only play an essential role in normal biological processes but also participate in the pathogenesis of diseases including type 2 diabetes (T2D) and comorbidities.1,2 However, conventional technologies (e.g. m6A-seq)3 require large amounts of input materials often prohibitive for clinically-feasible biospecimens (e.g. a few millilitres of blood or tissue from fine needle aspiration), we, therefore, developed a Strategy of Low-Input Multi-barcode m6A-seq (SLIM-m6A-seq) to facilitate transcriptome-wide m6A profiling with limited RNA.Using this new technology, we implicated novelm6A modifications and pathways in the development of acute myocardial infarction (AMI) in patients with T2D. Technically, SLIM-m6A-seq exploited the barcoding strategy to encode multiple samples with unique barcodes before pooling, library construction, and sequencing (Figure 1A and Table S1).4,5 The resulting profiles can be split by barcodes (Table S2) and traced back to the original samples. We first tested the feasibility of SLIM-m6A-seq in HeLa cells and calibrated them with spike-in oligonucleotides (Note S1 and Figure S1). Then we compared SLIM-m6A-seq of a pooled sample containing barcoded mRNA varying from 200 to 10 ng with m6A-seq of 800 ng mRNA (Note S1). The SLIM-m6A-seq results from input levels of 200 and 100 ng showed similar distribution (e.g. chromosome 1 in Figure S2A) and complexity with 2.56% relative standard deviation (RSD), compared to the data fromm6A-seq in 800 ng input, albeit substantially different starting amounts (Figure S3A). We further validated the capability of SLIM-m6A-seq for low-input samples in two 25-sample sets containing 10 ng (Init10) or 5 ng (Init5) fragmented mRNA from HEK293T
What problem does this paper attempt to address?